Identification
- Composition (DCI)
- brimonidine
- Manufacturer
- BOTTU S.A.
- ATC code
- S01EA05
- Presentation
- Flacon de 5 ml
- Schedule / Reimb.
- A
- Hospital price
- 53.40 MAD
Indications
Réduction de la pression intraoculaire élevée chez les patients atteints d'un glaucome à grand angle ou d'une hypertension oculaire: en monothérapie chez des patients chez lesquels un traitement topique par bêtabloquants est contre-indiqué, en association à d'autres traitements diminuant la pression intraoculaire.
Find an open pharmacy
On-call pharmacies near you
About IBRIMO 0.2 %
IBRIMO 0.2 % is marketed in Morocco by BOTTU S.A. and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of IBRIMO 0.2 %, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about IBRIMO 0.2 %
Answers to common questions from Moroccan patients about this drug.